Apply current evidence and guidelines to inform treatment selection for patients with recurrent/metastatic nasopharyngeal carcinoma. Integrate patient-and disease-specific factors into individualized treatment decisions involving immunotherapy-based regimens.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.5 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
89% of listed courses are free
25 of 28 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiothoracic Surgery
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Medical Genetics & Genomics
- Medical Oncology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Orthopaedic Trauma
- Pulmonary Disease
- Surgical Critical Care
- Surgical Oncology
- Thoracic Surgery
- Cardio-Vascular
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedAug 20, 2026
-
Last day to claim creditAug 21, 2027 10 months left
-
American Academy of Otolaryngology – Head & Neck Surgery Foundation Survivorship in Nasopharyngeal Carcinoma: The Importance of Comprehensive Otolaryngologic Care (2025 AMW)
-
PRIME Education, Inc. (PRIME®) Multidisciplinary Strategies in Head and Neck Cancer: Biomarkers, Immunotherapy, and Adverse Event Management
-
Clinical Care Options, LLC (dba Decera Clinical Education) Precision, Timing, and Teamwork in Melanoma Immunotherapy: Practical Strategies for Resectable and Metastatic Disease
-
touchIME, USF Health Optimizing outcomes in advanced endometrial carcinoma: Navigating guidelines, biomarker-driven immunotherapy and irAE management
-
touchIME, USF Health Targeting brain metastases in advanced NSCLC – The emerging impact of ADCs
-
touchIME, USF Health Evolving Paradigms in PNH Management: Interpreting the Latest Data
